相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Metabolomic profiles delineate potential role for sarcosine in prostate cancer progression
Arun Sreekumar et al.
NATURE (2009)
ProApoliploprotein A1 - A serum marker of brain metastases in lung cancer patient
Nicola Marchi et al.
CANCER (2008)
Serum proteomics and biomarkers in hepatocellular carcinoma and chronic liver disease
Noah T. Zinkin et al.
CLINICAL CANCER RESEARCH (2008)
Proteomics-driven cancer biomarker discovery: looking to the future
Richard J. Simpson et al.
CURRENT OPINION IN CHEMICAL BIOLOGY (2008)
Pathways connecting inflammation and cancer
Paola Allavena et al.
CURRENT OPINION IN GENETICS & DEVELOPMENT (2008)
Glycomics analysis of serum: a potential new biomarker for ovarian cancer?
G. S. Leiserowitz et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2008)
Serum levels of variants of transthyretin down-regulation in cholangiocarcinoma
Liyun Liu et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2008)
Reproducibility of mass spectrometry based protein profiles for diagnosis of breast cancer across clinical studies: A systematic review
Anne K. Callesen et al.
JOURNAL OF PROTEOME RESEARCH (2008)
Combined experimental and statistical strategy for mass spectrometry based serum protein profiling for diagnosis of breast cancer: A case-control study
Anne K. Callesen et al.
JOURNAL OF PROTEOME RESEARCH (2008)
An assessment of software solutions for the analysis of mass spectrometry based quantitative proteomics data
Lukas N. Mueller et al.
JOURNAL OF PROTEOME RESEARCH (2008)
Comparative proteomic analysis of non-small-cell lung cancer and normal controls using serum label-free quantitative shotgun technology
Jun Pan et al.
LUNG (2008)
Study of distinct protein profiles for early diagnosis of NSCLC using LCM and SELDI-TOF-MS
Shuanying Yang et al.
MEDICAL ONCOLOGY (2008)
Spiking of serum specimens with exogenous reporter peptides for mass spectrometry based protease profiling as diagnostic tool
Peter Findeisen et al.
RAPID COMMUNICATIONS IN MASS SPECTROMETRY (2008)
Proteomic profiling of urine for the detection of colon cancer
Douglas G. Ward et al.
PROTEOME SCIENCE (2008)
Proteomics, nanotechnology and molecular diagnostics
Christopher J. Johnson et al.
PROTEOMICS (2008)
Analytical validation of serum proteomic profiling for diagnosis of prostate cancer: Sources of sample bias
Dale McLerran et al.
CLINICAL CHEMISTRY (2008)
SELDI-TOF MS whole serum proteomic profiling with IMAC surface does not reliably detect prostate cancer
Dale McLerran et al.
CLINICAL CHEMISTRY (2008)
Serum diagnosis of diffuse large B-cell lymphomas and further identification of response to therapy using SELDI-TOF-MS and tree analysis patterning
Xing Zhang et al.
BMC CANCER (2007)
Proteomic profiling identifies afamin as a potential biomarker for ovarian cancer
David Jackson et al.
CLINICAL CANCER RESEARCH (2007)
Quantitative, multiplexed assays for low abundance proteins in plasma by targeted mass spectrometry and stable isotope dilution
Hasmik Keshishian et al.
MOLECULAR & CELLULAR PROTEOMICS (2007)
Body fluid proteomics for biomarker discovery: Lessons from the past hold the key to success in the future
David M. Good et al.
JOURNAL OF PROTEOME RESEARCH (2007)
Proteomic analysis of peripheral T lymphocytes, suitable circulating biosensors of strictly related diseases
M. Borro et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2007)
High sensitivity detection of plasma proteins by multiple reaction monitoring of N-glycosites
Jianru Stahl-Zeng et al.
MOLECULAR & CELLULAR PROTEOMICS (2007)
Proteomic analysis of human blood serum using peptide library beads
Lau Sennels et al.
JOURNAL OF PROTEOME RESEARCH (2007)
Reduced transthyretin expression in sera of lung cancer
Liyun Liu et al.
CANCER SCIENCE (2007)
Candidate markers for the detection of hepatocellular carcinoma in low-molecular weight fraction of serum
Radoslav Goldman et al.
CARCINOGENESIS (2007)
Addition of exogenous reporter peptides to serum samples before mass spectrometry-based protease profiling provides advantages over profiling of endogenous peptides
Peter Findeisen et al.
CLINICAL CHEMISTRY (2007)
MALDI imaging mass spectrometry: molecular snapshots of biochemical systems
Dale S. Cornett et al.
NATURE METHODS (2007)
Serum proteomic analysis identifies a highly sensitive and specific discriminatory pattern in stage 1 breast cancer
Claudio Belluco et al.
ANNALS OF SURGICAL ONCOLOGY (2007)
Comparative profiling of serum glycoproteome by sequential purification of glycoproteins and 2-nitrobenzenesulfenyl (NBS) stable isotope labeling: A new approach for the novel biomarker discovery for cancer
Koji Ueda et al.
JOURNAL OF PROTEOME RESEARCH (2007)
Proteomic analysis of peripheral blood mononuclear cells: Selective protein processing observed in patients with rheumatoid arthritis
Martin Schulz et al.
JOURNAL OF PROTEOME RESEARCH (2007)
The minimum information about a proteomics experiment (MIAPE)
Chris F. Taylor et al.
NATURE BIOTECHNOLOGY (2007)
SELDI-TOF MS versus prostate specific antigen analysis of prospective plasma samples in a nested case-control study of prostate cancer
Asa Skytt et al.
INTERNATIONAL JOURNAL OF CANCER (2007)
Alternative profiling platform based on MELDI and its applicability in clinical proteomics
Muhammad Najam-ul-Haq et al.
EXPERT REVIEW OF PROTEOMICS (2007)
Cancer immunomics using autoantibody signatures for biomarker discovery
Michel Caron et al.
MOLECULAR & CELLULAR PROTEOMICS (2007)
Diagnostic biomarkers differentiating metastatic melanoma patients from healthy controls identified by an integrated MALDI-TOF mass spectrometry/bioinformatic approach
Balwir Matharoo-Ball et al.
PROTEOMICS CLINICAL APPLICATIONS (2007)
A novel, high-throughput workflow for discovery and identification of serum carrier protein-bound peptide biomarker candidates in ovarian cancer samples
Mary F. Lopez et al.
CLINICAL CHEMISTRY (2007)
Toward a global characterization of the phosphoproteome in prostate cancer cells: Identification of phosphoproteins in the LNCaP cell line
Francesco Giorgianni et al.
ELECTROPHORESIS (2007)
Biomarker discovery in lung cancer - Promises and challenges of clinical proteomics
Ajit Bharti et al.
MASS SPECTROMETRY REVIEWS (2007)
Enzymes and related proteins as cancer biomarkers: A proteomic approach
Shu-Ling Liang et al.
CLINICA CHIMICA ACTA (2007)
Higher dimensional (Hi-D) separation strategies dramatically improve the potential for cancer biomarker detection in serum and plasma
Seth A. Hoffman et al.
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES (2007)
LC-MS/MS quantification of Zn-α2 glycoprotein:: A potential serum biomarker for prostate cancer
Olga P. Bondar et al.
CLINICAL CHEMISTRY (2007)
Posttranslational modifications of transthyretin are serum markers in patients with mycosis fungoides
Niko Escher et al.
NEOPLASIA (2007)
Antibody-based enrichment of peptides for mass-spectrometry-based quantification on magnetic beads of serum biomarkers
Jeffrey R. Whiteaker et al.
ANALYTICAL BIOCHEMISTRY (2007)
Identification of potential markers for the detection of pancreatic cancer through comparative serum protein expression profiling
Michael Ehmann et al.
PANCREAS (2007)
Global and targeted quantitative proteomics for biomarker discovery
Timothy D. Veenstra
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES (2007)
Unravelling in vitro variables of major importance for the outcome of mass spectrometry-based serum proteomics
Mikkel West-Norager et al.
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES (2007)
Head-to-head comparison of serum fractionation techniques
Jeffrey R. Whiteaker et al.
JOURNAL OF PROTEOME RESEARCH (2007)
Clinical proteomics: A need to define the field and to begin to set adequate standards
Harald Mischak et al.
PROTEOMICS CLINICAL APPLICATIONS (2007)
Validation of SELDI-TOF MS serum protein profiles for renal cell carcinoma in new populations
Judith Y. M. N. Engwegen et al.
LABORATORY INVESTIGATION (2007)
Achieving in-depth proteomics profiling by mass spectrometry
Natalie G. Ahn et al.
ACS CHEMICAL BIOLOGY (2007)
Coupling immunoaffinity techniques with MS for quantitative analysis of low-abundance protein biomarkers
Bradley L. Ackermann et al.
EXPERT REVIEW OF PROTEOMICS (2007)
Urinary biomarker profiling in transitional cell carcinoma
Nicholas P. Munro et al.
INTERNATIONAL JOURNAL OF CANCER (2006)
Proteome analysis of bronchoalveolar lavage in lung diseases
Barbara Magi et al.
PROTEOMICS (2006)
A serum proteomic pattern for the detection of colorectal adenocarcinoma using surface enhanced laser desorption and ionization mass spectrometry
Xing-pan Liu et al.
CANCER INVESTIGATION (2006)
New developments in profiling and imaging of proteins from tissue sections by MALDI mass spectrometry
Pierre Chaurand et al.
JOURNAL OF PROTEOME RESEARCH (2006)
Direct-tissue SELDI-TOF mass spectrometry analysis: A new application for clinical proteomics
Ali Bonam-rani et al.
CLINICAL CHEMISTRY (2006)
Serum peptidome patterns that distinguish metastatic thyroid carcinoma from cancer-free controls are unbiased by gender and age
Josep Villanueva et al.
MOLECULAR & CELLULAR PROTEOMICS (2006)
High resolution proteome/peptidome analysis of body fluids by capillary electrophoresis coupled with MS
Eric Schiffer et al.
PROTEOMICS (2006)
Advances and challenges in liquid chromatography-mass spectrometry-based proteomics profiling for clinical applications
Wei-Jun Qian et al.
MOLECULAR & CELLULAR PROTEOMICS (2006)
Strategies for plasma proteomic profiling of cancers
Gilbert S. Omenn
PROTEOMICS (2006)
Proteomic profiling of cholangiocarcinoma: Diagnostic potential of SELDI-TOF MS in malignant bile duct stricture
Christopher J. Scarlett et al.
HEPATOLOGY (2006)
Evaluation of apolipoprotein A1 and posttranslationally modified forms of transthyretin as biomarkers for ovarian cancer detection in an independent study population
Lee E. Moore et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2006)
Peptidomics for cancer diagnosis: Present and future
Eleftherios P. Diamandis
JOURNAL OF PROTEOME RESEARCH (2006)
Standards for systems biology
Alvis Brazma et al.
NATURE REVIEWS GENETICS (2006)
Protein biomarker discovery and validation: the long and uncertain path to clinical utility
Nader Rifai et al.
NATURE BIOTECHNOLOGY (2006)
The MALDI-TOF mass spectrometric view of the plasma proteome and peptidome
Glen L. Hortin
CLINICAL CHEMISTRY (2006)
Identification of serum biomarkers for colon cancer by proteomic analysis
D. G. Ward et al.
BRITISH JOURNAL OF CANCER (2006)
Quantification of fragments of human serum inter-α-trypsin inhibitor heavy chain 4 by a surface-enhanced laser desorption/ionization-based immunoassay
Jin Song et al.
CLINICAL CHEMISTRY (2006)
Serum proteomic profiling by matrix-assisted laser desorption-ionization time-of-flight mass spectrometry for cancer diagnosis: Next steps
Eleftherios P. Diamandis
CANCER RESEARCH (2006)
Identification of complement C3a as a candidate biomarker in human chronic hepatitis C and HCV-related hepatocellular carcinoma using a proteomics approach
I-Neng Lee et al.
PROTEOMICS (2006)
Predicting the clinical outcome of congenital unilateral ureteropelvic junction obstruction in newborn by urinary proteome analysis
S Decramer et al.
NATURE MEDICINE (2006)
Discovery and validation of new protein biomarkers for 4 urothelial cancer: a prospective analysis
D Theodorescu et al.
LANCET ONCOLOGY (2006)
Challenges in deriving high-confidence protein identifications from data gathered by a HUPO plasma proteome collaborative study
DJ States et al.
NATURE BIOTECHNOLOGY (2006)
Serum biomarkers for detection of breast cancers: a prospective study
C Mathelin et al.
BREAST CANCER RESEARCH AND TREATMENT (2006)
Biomarker discovery from the plasma proteome using multidimensional fractionation proteomics
HJ Lee et al.
CURRENT OPINION IN CHEMICAL BIOLOGY (2006)
A rapid test for the diagnosis of thrombotic thrombocytopenic purpura using surface enhanced laser desorption/ionization time-of-flight (SELDI-TOF)-mass spectrometry
M Jin et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2006)
Proteomic-based discovery and characterization of glycosylated eosinophil-derived neurotoxin and COOH-terminal osteopontin fragments for ovarian cancer in urine
B Ye et al.
CLINICAL CANCER RESEARCH (2006)
Differential exoprotease activities confer tumor-specific serum peptidome patterns
J Villanueva et al.
JOURNAL OF CLINICAL INVESTIGATION (2006)
Two-dimensional fluorescence difference gel electrophoresis for comparative proteomics profiling
Nilesh S. Tannu et al.
NATURE PROTOCOLS (2006)
Inflammatory protein profile during systemic high dose interleukin-2 administration
L Rossi et al.
PROTEOMICS (2006)
MALDI-TOF serum protein profiling for the detection of breast cancer
Mirre E. de Noo et al.
ONKOLOGIE (2006)
Sampling and analytical strategies for biomarker discovery using mass spectrometry
Thomas P. Conrads et al.
BIOTECHNIQUES (2006)
Application of bioaffinity mass spectrometry for analysis of ligands
YS Zhu et al.
THERAPEUTIC DRUG MONITORING (2005)
Independent validation of candidate breast cancer serum biomarkers identified by mass spectrometry
JN Li et al.
CLINICAL CHEMISTRY (2005)
Preanalytical impact of sample handling on proteome profiling experiments with matrix-assisted laser desorption/ionization time-of-flight mass spectrometry
P Findeisen et al.
CLINICAL CHEMISTRY (2005)
Possible detection of pancreatic cancer by plasma protein profiling
K Honda et al.
CANCER RESEARCH (2005)
Local proteolytic activity in tumor cell invasion and metastasis
T Ludwig
BIOESSAYS (2005)
Identification of human hepatocellular carcinoma-related biomarkers by two-dimensional difference gel electrophoresis and mass spectrometry
IN Lee et al.
JOURNAL OF PROTEOME RESEARCH (2005)
Characterization of serum biomarkers for detection of early stage ovarian cancer
KR Kozak et al.
PROTEOMICS (2005)
Capillary electrophoresis -: Mass spectrometry as a powerful tool in clinical diagnosis and biomarker discovery
W Kolch et al.
MASS SPECTROMETRY REVIEWS (2005)
Proteomic tracking of serum protein isoforms as screening biomarkers of ovarian cancer
N Ahmed et al.
PROTEOMICS (2005)
Microheterogeneity of transthyretin in serum and ascitic fluid of ovarian cancer patients -: art. no. 133
B Gericke et al.
BMC CANCER (2005)
Identification of 2 serum biomarkers of renal cell carcinoma by surface enhanced laser desorption/ionization mass spectrometry
T Hara et al.
JOURNAL OF UROLOGY (2005)
Ovarian cancer marker of 11.7 kDa detected by proteomics is a serum amyloid A1
SA Moshkovskii et al.
PROTEOMICS (2005)
Influences of blood sample processing on low-molecular-weight proteome identified by surface-enhanced laser desorption/ionization mass spectrometry
RE Banks et al.
CLINICAL CHEMISTRY (2005)
A streamlined platform for high-content functional proteomics of primary human specimens
N Jessani et al.
NATURE METHODS (2005)
Characterization of proteins in human pancreatic cancer serum using differential gel electrophoresis and tandem mass spectrometry
KH Yu et al.
JOURNAL OF PROTEOME RESEARCH (2005)
Sample handling for mass spectrometric proteomic investigations of human sera
M West-Hielsen et al.
ANALYTICAL CHEMISTRY (2005)
Investigating diversity in human plasma proteins
D Nedelkov et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Analytical and preanalytical biases in serum proteomic pattern analysis for breast cancer diagnosis
A Karsan et al.
CLINICAL CHEMISTRY (2005)
SELDI-TOF-MS: the proteomics and bioinformatics approaches in the diagnosis of breast cancer
Y Hu et al.
BREAST (2005)
Application of serum SELDI proteomic patterns in diagnosis of lung cancer
SY Yang et al.
BMC CANCER (2005)
Quality control and quality assessment of data from surface-enhanced laser desorption/ionization (SELDI) time-of flight (TOF) mass spectrometry (MS)
HX Hong et al.
BMC BIOINFORMATICS (2005)
Classification of cancer types by measuring variants of host response proteins using SELDI serum assays
ET Fung et al.
INTERNATIONAL JOURNAL OF CANCER (2005)
Correcting common errors in identifying cancer-specific serum peptide signatures
J Villanueva et al.
JOURNAL OF PROTEOME RESEARCH (2005)
Pilot study of capillary electrophoresis coupled to mass spectrometry as a tool to define potential prostate cancer biomarkers in urine
D Theodorescu et al.
ELECTROPHORESIS (2005)
Discovery and identification of α-defensins as low abundant, tumor-derived serum markers in colorectal cancer
C Melle et al.
GASTROENTEROLOGY (2005)
Standardized approach to proteome profiling of human serum based on magnetic bead separation and matrix-assisted laser desorption/ionization time-of-flight mass spectrometry
S Baumann et al.
CLINICAL CHEMISTRY (2005)
Low molecular weight proteomic information distinguishes metastatic from benign pheochromocytoma
FM Brouwers et al.
ENDOCRINE-RELATED CANCER (2005)
Proteomic analysis of nipple aspirate fluid using SELDI-TOF-MS
ER Sauter et al.
INTERNATIONAL JOURNAL OF CANCER (2005)
Using tree analysis pattern and SELDI-TOF-MS to discriminate transitional cell carcinoma of the bladder cancer from noncancer patients
WW Liu et al.
EUROPEAN UROLOGY (2005)
Identification of serum amyloid a as a biomarker to distinguish prostate cancer patients with bone lesions
L Le et al.
CLINICAL CHEMISTRY (2005)
Tissue profiling by mass spectrometry - A review of methodology and applications
RL Caldwell et al.
MOLECULAR & CELLULAR PROTEOMICS (2005)
Proteomic detection of pro state-specific antigen using a serum fractionation procedure:: potential implication for new low-abundance cancer biomarkers detection
K Solassol et al.
ANALYTICAL BIOCHEMISTRY (2005)
SELDI-TOF MS profiling of serum for detection of the progression of chronic hepatitis C to hepatocellular carcinoma
EE Schwegler et al.
HEPATOLOGY (2005)
Identification of hemoglobin-α and -β subunits as potential serum biomarkers for the diagnosis and prognosis of ovarian cancer
WS Ahn et al.
CANCER SCIENCE (2005)
Opinion - Bias as a threat to the validity of cancer molecular-marker research
DF Ransohoff
NATURE REVIEWS CANCER (2005)
Upregulated expression of human neutrophil peptides 1, 2 and 3 (HNP 1-3) in colon cancer serum and tumours: a biomarker study
J Albrethsen et al.
BMC CANCER (2005)
Prediction of pancreatic cancer by serum biomarkers using surface-enhanced laser desorption/ionization-based decision tree classifi cation
Y Yu et al.
ONCOLOGY (2005)
Diagnostic protein discovery using liquid chromatography/mass spectrometry for proteolytic peptide targeting
JM Koomen et al.
RAPID COMMUNICATIONS IN MASS SPECTROMETRY (2005)
Evaluation of serum protein profiling by surface-enhanced laser desorption/ionization time-of-flight mass spectrometry for the detection of prostate cancer: I. Assessment of platform reproducibility
OJ Semmes et al.
CLINICAL CHEMISTRY (2005)
Identification of a new marker of hepatocellular carcinoma by serum protein profiling of patients with chronic liver diseases
V Paradis et al.
HEPATOLOGY (2005)
Characterization of the human urinary proteome: A method for high-resolution display of urinary proteins on two-dimensional electrophoresis gels with a yield of nearly 1400 distinct protein spots
R Pieper et al.
PROTEOMICS (2004)
Reproducibility of SELDI-TOF protein patterns in serum: comparing datasets from different experiments
KA Baggerly et al.
BIOINFORMATICS (2004)
Serum peptide profiling by magnetic particle-assisted, automated sample processing and MALDI-TOF mass spectrometry
J Villanueva et al.
ANALYTICAL CHEMISTRY (2004)
Computational protein biomarker prediction: a case study for prostate cancer
M Wagner et al.
BMC BIOINFORMATICS (2004)
Serum diagnosis of pancreatic adenocarcinoma using surface-enhanced laser desorption and ionization mass spectrometry
J Koopmann et al.
CLINICAL CANCER RESEARCH (2004)
Diagnosis of pancreatic cancer using serum proteomic profiling
S Bhattacharyya et al.
NEOPLASIA (2004)
Three biomarkers identified from serum proteomic analysis for the detection of early stage ovarian cancer
Z Zhang et al.
CANCER RESEARCH (2004)
Protein profiling in urine for the diagnosis of bladder cancer
A Vlahou et al.
CLINICAL CHEMISTRY (2004)
Artificial neural networks analysis of surface-enhanced laser desorption/ionization mass spectra of serum protein pattern distinguishes colorectal cancer from healthy population
YD Chen et al.
CLINICAL CANCER RESEARCH (2004)
The use of plasma surface-enhanced laser desorption/ionization time-of-flight mass spectrometry proteomic patterns for detection of head and neck squamous cell cancers
SG Soltys et al.
CLINICAL CANCER RESEARCH (2004)
Bioinformatics strategies for proteomic profiling
CN White et al.
CLINICAL BIOCHEMISTRY (2004)
Serum protein profiling by SELDI mass spectrometry: detection of multiple variants of serum amyloid alpha in renal cancer patients
J Tolson et al.
LABORATORY INVESTIGATION (2004)
Capillary electrophoresis coupled to mass spectrometer for automated and robust pofypaptide determination in body fluids for clinical use
T Kaiser et al.
ELECTROPHORESIS (2004)
Diagnostic protein discovery using proteolytic peptide targeting and identification
JM Koomen et al.
RAPID COMMUNICATIONS IN MASS SPECTROMETRY (2004)
A technical triade for proteomic identification and characterization of cancer biomarkers
C Melle et al.
CANCER RESEARCH (2004)
Proteomic patterns established with capillary electrophoresis and mass spectrometry for diagnostic purposes
EM Weissinger et al.
KIDNEY INTERNATIONAL (2004)
Extracellular proteases as targets for treatment of cancer metastases
M Lee et al.
CHEMICAL SOCIETY REVIEWS (2004)
Serum proteomic profiling can discriminate prostate cancer from benign prostates in men with total prostate specific antigen levels between 2.5 and 15.0 ng/ml
DK Ornstein et al.
JOURNAL OF UROLOGY (2004)
Comparison of statistical methods for classification of ovarian cancer using mass spectrometry data
BL Wu et al.
BIOINFORMATICS (2003)
Diagnostic potential of serum proteomic patterns in prostate cancer
LL Bañez et al.
JOURNAL OF UROLOGY (2003)
Mass spectrometry-based clinical proteomics
W Pusch et al.
PHARMACOGENOMICS (2003)
Processing of serum proteins underlies the mass spectral fingerprinting of myocardial infarction
J Marshall et al.
JOURNAL OF PROTEOME RESEARCH (2003)
Temperature range of thermodynamic stability for the native state of reversible two-state proteins
S Kumar et al.
BIOCHEMISTRY (2003)
Comprehensive proteomic profiling identifies serum proteomic signatures for detection of hepatocellular carcinoma and its subtypes
TCW Poon et al.
CLINICAL CHEMISTRY (2003)
Mass spectrometry-based proteomics
R Aebersold et al.
NATURE (2003)
Pattern analysis of serum proteome distinguishes renal cell carcinoma from other urologic diseases and healthy persons
Y Won et al.
PROTEOMICS (2003)
The STARD statement for reporting studies of diagnostic accuracy: Explanation and elaboration
PM Bossuyt et al.
CLINICAL CHEMISTRY (2003)
The human plasma proteome - History, character, and diagnostic prospects
NL Anderson et al.
MOLECULAR & CELLULAR PROTEOMICS (2002)
Use of proteomic patterns in serum to identify ovarian cancer
EF Petricoin et al.
LANCET (2002)
Protein status in pancreatitis-transthyretin is a sensitive biomarker of malnutrition in acute and chronic pancreatitis
N Lasztity et al.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2002)
Osteopontin, a novel substrate for matrix metalloproteinase-3 (stromelysin-1) and matrix metalloproteinase-7 (matrilysin)
R Agnihotri et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Development of a novel proteomic approach for the detection of transitional cell carcinoma of the bladder in urine
A Vlahou et al.
AMERICAN JOURNAL OF PATHOLOGY (2001)
Serum protein profiles of patients with pancreatic cancer and chronic pancreatitis: searching for a diagnostic protein pattern
A Valerio et al.
RAPID COMMUNICATIONS IN MASS SPECTROMETRY (2001)
分享论文
